Max Healthcare Institute DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.76×	0.86×	0.77×	0.77×	1.04×
	0.93×	0.93×	0.94×	1.09×	1.05×
	21.3%	21.5%	21.2%	23.1%	22.1%
	0.52×	0.52×	0.52×	0.49×	0.47×
	1.62×	1.60×	1.62×	1.43×	1.36×
	12.7%	14.4%	12.9%	13.7%	15.5%
	14.3%	14.3%	12.1%	13.3%	16.1%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MAXHEALTH₹851.15

Max Healthcare Institute Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP FORTIS MEDANTA DRREDDY CIPLA SUNPHARMA DIVISLAB TORNTPHARMMcap ₹82,828 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	1.04	0.77	0.77	0.86	0.76
Interest Burden (Pretax/EBIT) ×	1.05	1.09	0.94	0.93	0.93
EBIT Margin %	22.10	23.07	21.19	21.45	21.33
Asset Turnover ×	0.47	0.49	0.52	0.52	0.52
Financial Leverage (Assets/Equity) ×	1.36	1.43	1.62	1.60	1.62
ROE (5-step product, year-end total equity) %	15.50	13.68	12.91	14.36	12.74
ROE (owners' profit / average owners' equity) %	16.12	13.29	12.10	14.33	14.33

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 146%.